February 21, 2022
Our CEO Hideki Ando won the Jury Prize at the Tohoku Growth Accelerator (TGA) Festival 2022.
October 11, 2021
Project of Sky Pharma was adopted as the 2021 TOHOKU GROWTH ACCELERATOR (Growth course) Program.
October 07, 2021
International application has published on 07 October 2021 under No. WO 2021/201170
August 20, 2021
Sky Pharma Co.,Ltd. aims to develop regenerative medicine products from low molecular weight compounds.
Sky Pharma Co.,Ltd. is engaged in the research and development of drug discovery for diseases and injuries for which complete recovery is considered difficult at present, including glaucoma and spinal cord injury.
Contact the number below for inquiries regarding collaboration and partnership with Sky Pharma Co.,Ltd.
Contact the number below for inquiries regarding the businesses and products of Sky Pharma Co.,Ltd.